ArticleScientific reports2017

Clinical experience with the artificial bone graft substitute Calcibon used following curettage of benign and low-grade malignant bone tumors.

Joerg Friesenbichler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.